Response of borderline resectable pancreatic cancer to neoadjuvant therapy is not reflected by radiographic indicators

Experience with preoperative therapy for other cancers has led to an assumption that borderline resectable pancreatic cancers can be converted to resectable cancers with preoperative therapy. In this study, the authors sought to determine the rate at which neoadjuvant therapy is associated with a reduction in the size or stage of borderline resectable tumors.Patients who had borderline resectable pancreatic cancer and received neoadjuvant...